CCLA Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arthur J. Gallagher & Co
AJG
|
+$112M |
| 2 |
Broadcom
AVGO
|
+$112M |
| 3 |
Blackstone Secured Lending
BXSL
|
+$65.2M |
| 4 |
Icon
ICLR
|
+$47.2M |
| 5 |
Coca-Cola
KO
|
+$29.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$133M |
| 2 |
PepsiCo
PEP
|
+$119M |
| 3 |
Starbucks
SBUX
|
+$116M |
| 4 |
Humana
HUM
|
+$115M |
| 5 |
Nike
NKE
|
+$88.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.64% |
| 2 | Financials | 23.33% |
| 3 | Healthcare | 17.3% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Industrials | 7.66% |
Similar funds
CCLA Investment Management's Q4 2024 Portfolio in Review
As of Q4 2024, CCLA Investment Management held 71 positions worth $6.31B, down 2.9% from $6.49B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
CCLA Investment Management withdrew a net $340M in Q4 2024, closing 12 positions and reducing 20 holdings. Its most notable exit was Edwards Lifesciences, an estimated $133M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
Against the trend, CCLA Investment Management opened a new position in Arthur J. Gallagher & Co worth $110M.
- CCLA Investment Management's largest Q4 2024 buy was Arthur J. Gallagher & Co: 385,937 shares worth $110M.
- CCLA Investment Management added most to Broadcom in Q4 2024, an estimated $112M increase.
- CCLA Investment Management's biggest Q4 2024 reduction was TransUnion, cutting an estimated $70.6M.
- CCLA Investment Management fully exited Edwards Lifesciences in Q4 2024, selling an estimated $133M.
- CCLA Investment Management's ten largest holdings make up 29% of its $6.31B portfolio in Q4 2024.
- CCLA Investment Management opened 2 new positions and closed 12 in Q4 2024.
- CCLA Investment Management's portfolio value fell 2.9% quarter-over-quarter to $6.31B.
Based on CCLA Investment Management's 13F filing for Q4 2024, filed 14 Jan 2025.